Therakind Limited

POWER SEARCH PRICING

SOLUTIONS

therakind limited Company Information

Company Number

05876561

Next Accounts

Jan 2026

Directors

Susan Conroy

Paul Mann

View All

Shareholders

vindeca limited

Group Structure

View All

Industry

Manufacture of basic pharmaceutical products

Registered Address

314 regents park road, third floor, london, N3 2JX

Website

www.therakind.com

therakind limited Estimated Valuation

£51.2m

Pomanda estimates the enterprise value of THERAKIND LIMITED at £51.2m based on an EBITDA of £8m and a 6.41x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Therakind Limited is a live company located in london, N3 2JX with a Companies House number of 05876561. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in July 2006, it's largest shareholder is vindeca limited with a 100% stake. Therakind Limited is a established, small sized company, Pomanda has estimated its turnover at £2.9m with high growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Therakind Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 3 areas for improvement. Company Health Check FAQs

Health Rating5out of 5

7 Strong

2 Regular

3 Weak

Size

annual sales of £2.9m, make it smaller than the average company (£37.1m)

Growth

3 year (CAGR) sales growth of 21%, show it is growing at a faster rate (5.2%)

EXPORT

Therakind Limited's latest turnover from April 2024 is estimated at £2.9 million and the company has net assets of £11.4 million. According to their latest financial statements, Therakind Limited has 19 employees and maintains cash reserves of £4.3 million as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Turnover	2,929,842	3,116,647	2,764,954	1,665,086	2,616,748	1,709,967	1,507,122	1,470,725	971,391	2,915,759	3,125,538	947,759	393,505	551,402	601,263
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	1,858,242	1,932,148	1,735,313	1,006,853	1,635,757	1,033,998	920,045	901,963	589,451	1,846,124	1,945,924	591,772	236,454	331,180	371,692
Gross Profit	1,071,600	1,184,499	1,029,641	658,233	980,991	675,969	587,076	568,762	381,940	1,069,635	1,179,614	355,986	157,051	220,222	229,571
Admin Expenses	-6,901,242	1,520,606	1,694,353	-2,788,312	794,744	-85,574	-63,752	-265,168	-20,984	1,081,653	1,250,649	569,580	382,927	-176,991	1,057,952
Operating Profit	7,972,842	-336,107	-664,712	3,446,545	186,247	761,543	650,828	833,930	402,924	-12,018	-71,035	-213,594	-225,876	397,213	-828,381
Interest Payable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Receivable	216,978	183,120	38,783	4,048	2,331	15,952	7,210	2,331	4,405	5,443	4,233	2,271	3,128	1,817	111
Pre-Tax Profit	8,189,820	-152,987	-625,929	3,450,593	188,578	777,495	658,038	836,260	407,329	-6,575	-66,802	-211,323	-222,748	399,030	-828,270
Tax	-2,047,455	0	0	-655,613	-35,830	-147,724	-125,027	-158,889	-81,466	0	0	0	0	-103,748	0
Profit After Tax	6,142,365	-152,987	-625,929	2,794,980	152,748	629,771	533,011	677,371	325,863	-6,575	-66,802	-211,323	-222,748	295,282	-828,270
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	6,142,365	-152,987	-625,929	2,794,980	152,748	629,771	533,011	677,371	325,863	-6,575	-66,802	-211,323	-222,748	295,282	-828,270
Employee Costs	1,230,259	1,051,652	947,625	1,007,440	959,821	350,332	281,825	307,042	226,313	691,152	706,665	202,834	77,073	113,687	117,701
Number Of Employees	19	17	15	16	16	6	5	6	5	15	17	5	2	3	3
EBITDA*	7,975,337	-332,615	-641,711	3,470,680	208,889	782,086	674,734	842,931	411,431	-7,412	-68,892	-209,892	-186,419	502,800	-824,787

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Tangible Assets	3,887	5,216	4,299	7,368	12,726	6,317	4,638	8,668	13,570	19,348	2,735	2,847	6,441	12,219	15,603
Intangible Assets	0	0	0	18,319	36,637	54,956	73,275	91,593	0	0	0	0	0	33,500	133,500
Investments & Other	100	100	100	100	100	100	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	3,987	5,316	4,399	25,787	49,463	61,373	77,913	100,261	13,570	19,348	2,735	2,847	6,441	45,719	149,103
Stock & work in progress	137,999	139,880	4,652	44,319	15,989	0	0	0	0	0	0	0	0	0	0
Trade Debtors	124,230	444,892	463,686	25,062	410,895	376,270	303,150	289,055	184,610	416,415	300,315	187,547	68,117	96,019	99,591
Group Debtors	8,585,083	0	0	0	23,569	0	0	0	0	0	0	0	0	0	0
Misc Debtors	115,627	1,074,321	485,847	750,442	310,440	237,256	233,987	479,443	261,327	0	0	0	0	0	0
Cash	4,260,977	4,004,837	4,612,557	5,729,589	2,365,448	2,295,815	1,957,964	926,039	938,754	823,302	1,354,056	339,216	568,998	682,349	44,412
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	13,223,916	5,663,930	5,566,742	6,549,412	3,126,341	2,909,341	2,495,101	1,694,537	1,384,691	1,239,717	1,654,371	526,763	637,115	778,368	144,003
total assets	13,227,903	5,669,246	5,571,141	6,575,199	3,175,804	2,970,714	2,573,014	1,794,798	1,398,261	1,259,065	1,657,106	529,610	643,556	824,087	293,106
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	422,978	217,893	48,405	137,641	155,621	59,723	72,450	135,708	101,343	635,721	1,027,187	82,909	59,099	66,531	76,131
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	1,433,620	158,080	214,117	657,270	78,075	121,631	340,975	32,512	347,711	0	0	0	0	0	0
total current liabilities	1,856,598	375,973	262,522	794,911	233,696	181,354	413,425	168,220	449,054	635,721	1,027,187	82,909	59,099	66,531	76,131
loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
provisions	972	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total long term liabilities	972	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total liabilities	1,857,570	375,973	262,522	794,911	233,696	181,354	413,425	168,220	449,054	635,721	1,027,187	82,909	59,099	66,531	76,131
net assets	11,370,333	5,293,273	5,308,619	5,780,288	2,942,108	2,789,360	2,159,589	1,626,578	949,207	623,344	629,919	446,701	584,457	757,556	216,975
total shareholders funds	11,370,333	5,293,273	5,308,619	5,780,288	2,942,108	2,789,360	2,159,589	1,626,578	949,207	623,344	629,919	446,701	584,457	757,556	216,975

	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Operating Activities
Operating Profit	7,972,842	-336,107	-664,712	3,446,545	186,247	761,543	650,828	833,930	402,924	-12,018	-71,035	-213,594	-225,876	397,213	-828,381
Depreciation	2,495	3,492	4,682	5,817	4,323	2,224	5,588	9,001	8,507	4,606	2,143	3,702	5,957	5,587	3,594
Amortisation	0	0	18,319	18,318	18,319	18,319	18,318	0	0	0	0	0	33,500	100,000	0
Tax	-2,047,455	0	0	-655,613	-35,830	-147,724	-125,027	-158,889	-81,466	0	0	0	0	-103,748	0
Stock	-1,881	135,228	-39,667	28,330	15,989	0	0	0	0	0	0	0	0	0	0
Debtors	7,305,727	569,680	174,029	30,600	131,378	76,389	-231,361	322,561	29,522	116,100	112,768	119,430	-27,902	-3,572	99,591
Creditors	205,085	169,488	-89,236	-17,980	95,898	-12,727	-63,258	34,365	-534,378	-391,466	944,278	23,810	-7,432	-9,600	76,131
Accruals and Deferred Income	1,275,540	-56,037	-443,153	579,195	-43,556	-219,344	308,463	-315,199	347,711	0	0	0	0	0	0
Deferred Taxes & Provisions	972	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	105,633	-924,072	-1,308,462	3,317,352	78,034	325,902	1,026,273	80,647	113,776	-514,978	762,618	-305,512	-165,949	393,024	-848,247
Investing Activities
capital expenditure	-1,166	-4,409	-1,613	-459	-10,732	-3,903	-1,558	-95,692	-2,729	-21,219	-2,031	-108	-179	-2,203	-152,697
Change in Investments	0	0	0	0	0	100	0	0	0	0	0	0	0	0	0
cash flow from investments	-1,166	-4,409	-1,613	-459	-10,732	-4,003	-1,558	-95,692	-2,729	-21,219	-2,031	-108	-179	-2,203	-152,697
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
share issue	-65,305	137,641	154,260	43,200	0	0	0	0	0	0	250,020	73,567	49,649	245,299	1,045,245
interest	216,978	183,120	38,783	4,048	2,331	15,952	7,210	2,331	4,405	5,443	4,233	2,271	3,128	1,817	111
cash flow from financing	151,673	320,761	193,043	47,248	2,331	15,952	7,210	2,331	4,405	5,443	254,253	75,838	52,777	247,116	1,045,356
cash and cash equivalents
cash	256,140	-607,720	-1,117,032	3,364,141	69,633	337,851	1,031,925	-12,715	115,452	-530,754	1,014,840	-229,782	-113,351	637,937	44,412
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	256,140	-607,720	-1,117,032	3,364,141	69,633	337,851	1,031,925	-12,715	115,452	-530,754	1,014,840	-229,782	-113,351	637,937	44,412

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for therakind limited. Get real-time insights into therakind limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for therakind limited by selecting its closest rivals, whether from the MANUFACTURING sector, other small companies, companies in N 3 area or any other competitors across 12 key performance metrics.

THERAKIND LIMITED group structure

Therakind Limited has no subsidiary companies.

Ultimate parent company

THERAKIND LIMITED

05876561

THERAKIND LIMITED Shareholders

vindeca limited

100%

Therakind Limited currently has 3 directors. The longest serving directors include Dr Susan Conroy (Mar 2007) and Mr Paul Mann (Mar 2024).

officer	country	age	start	end	role
Dr Susan Conroy	England	54 years	Mar 2007	-	Director
Mr Paul Mann	England	56 years	Mar 2024	-	Director
Ms Louise Rawcliffe	England	60 years	Mar 2024	-	Director

P&L

April 2024

turnover

2.9m

-6%

operating profit

gross margin

36.6%

-3.76%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

April 2024

net assets

11.4m

+1.15%

total assets

13.2m

+1.33%

cash

4.3m

+0.06%

net assets

Total assets minus all liabilities

Similar Companies

osteoporosis research ltd

north star healthcare limited

4.5

donglun limited

3.5

cool herbals limited

1.5

medical export company limited

2.5

company number

05876561

Type

Private limited with Share Capital

industry

21100 - Manufacture of basic pharmaceutical products

incorporation date

July 2006

ultimate parent company

None

previous names

N/A

address

314 regents park road, third floor, london, N3 2JX

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to therakind limited.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for THERAKIND LIMITED. This can take several minutes, an email will notify you when this has completed.

therakind limited Company Information

therakind limited Estimated Valuation

therakind limited Estimated Valuation

therakind limited Estimated Valuation

Therakind Limited Overview

Therakind Limited Health Check

THERAKIND LIMITED financials

therakind limited Credit Report and Business Information

Therakind Limited Competitor Analysis

therakind limited Ownership

therakind limited directors

therakind limited company details

therakind limited Charges & Mortgages

therakind limited Capital Raised & Share Issues BETA

therakind limited Companies House Filings - See Documents